4.6 Article

Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 81, Issue 9, Pages 958-962

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp.2009.181636

Keywords

-

Ask authors/readers for more resources

Background Heat shock protein 27 (HSP27) mutations have been reported to cause both Charcot-Marie-Tooth disease (CMT) type 2F and distal hereditary motor neuropathy (dHMN) although never previously in a single family. Objective To analyse clinical and electrophysiological findings obtained in a single large Sardinian family bearing the HSP27 R127W mutation. Methods Twenty-one members of a five generation Sardinian family have been studied, including thirteen members affected by peroneal muscular atrophy and proved heterozygous for the known HSP27 R127W mutation. Twelve patients and eight unaffected relatives were subjected to clinical examination. A standardised electrophysiological study was performed in eleven patients and six unaffected relatives. Results Mean age at onset (+/- SD) was 31.2 +/- 7.2 years. Mean age at investigation was 45.2 +/- 12.9 years and mean disease duration at the time of investigation was 14 +/- 12.9 years. According to current criteria for CMT2 and dHMN, of the 10 patients who had undergone both clinical and neurophysiological examination, five were diagnosed as CMT2, two as dHMN and a further two patients were labelled as an intermediate type. Finally, due to the presence of spastic paraplegia, the index patient did not meet established criteria for the diagnosis of CMT or dHMN. Discussion Findings obtained in the present study, broadening the spectrum of clinical manifestations of disorders associated with HSP27 mutations, support the hypothesis of a continuum between CMT2 and dHMN forms and suggest a possible common spectrum between these entities and several forms of CMT plus pyramidal features ( HMSN V), providing important implications for molecular genetic testing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Clinical Neurology

Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD

Alessandro Dinoto, Elia Sechi, Sergio Ferrari, Alberto Gajofatto, Riccardo Orlandi, Paolo Solla, Alessandra Maccabeo, Giorgia Teresa Maniscalco, Vincenzo Andreone, Arianna Sartori, Paolo Manganotti, Sarah Rasia, Ruggero Capra, Chiara Rosa Mancinelli, Sara Mariotto

Summary: This retrospective multicenter Italian study assessed the frequency of relapses after SARS-CoV-2 vaccination in patients with MOGAD and AQP4-IgG+NMOSD. The study found that there was no relapse in the MOGAD group, while the relapse risk in the AQP4-IgG+ NMOSD group was 4%.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)

Article Neurosciences

Olfactory Impairment in Parkinson's Disease Patients with Tremor Dominant Subtype Compared to Those with Akinetic Rigid Dominant Subtype: A Pilot Study

Paolo Solla, Carla Masala, Tommaso Ercoli, Gianni Orofino, Francesco Loy, Ilenia Pinna, Laura Fadda, Giovanni Defazio

Summary: This study found significant olfactory dysfunction in PD patients with the akinetic-rigid dominant (ARD) subtype, with a lower odor threshold compared to the tremor-dominant (TD) subtype. There may be different pathophysiological mechanisms between the different clinical subtypes of PD.

BRAIN SCIENCES (2022)

Article Neurosciences

Rasagiline Withdrawal Syndrome in Parkinson's Disease

Paolo Solla, Tommaso Ercoli, Carla Masala, Gianni Orofino, Laura Fadda, Davide Giacomo Corda, Ignazio Roberto Zarbo, Mario Meloni, Elia Sechi, Caterina Francesca Bagella, Giovanni Defazio

Summary: This article reports three PD patients who developed a severe withdrawal syndrome after discontinuing the use of rasagiline. The syndrome was characterized by prominent psychiatric disorders and autonomic symptoms, resembling dopamine agonist withdrawal syndrome. This report highlights the importance of closely monitoring PD patients undergoing rasagiline suspension for withdrawal symptoms and provides interesting insights into the role of rasagiline and other MAO-B inhibitors in mood disorders.

BRAIN SCIENCES (2022)

Article Clinical Neurology

Relationship between risk and protective factors and clinical features of Parkinson?s disease

Daniele Belvisi, Roberta Pellicciari, Andrea Fabbrini, Matteo Costanzo, Gaia Ressa, Sara Pietracupa, Maria De Lucia, Nicola Modugno, Francesca Magrinelli, Carlo Dallocchio, Tommaso Ercoli, Alessandra Nicoletti, Mario Zappia, Paolo Solla, Matteo Bologna, Giovanni Fabbrini, Michele Tinazzi, Antonella Conte, Alfredo Berardelli, Giovanni Defazio

Summary: This multicenter study aimed to investigate the relationship between risk factors and clinical motor and non-motor features in Parkinson's disease (PD) patients. The results showed that coffee consumption was associated with older age at onset and milder motor symptom severity. Patients with dyspepsia before PD had more severe non-motor symptoms, while patients who performed physical activity before PD had milder non-motor symptoms.

PARKINSONISM & RELATED DISORDERS (2022)

Article Medicine, Research & Experimental

Therapeutic advantages of combined gene/cell therapy strategies in a murine model of GM2 gangliosidosis

Davide Sala, Francesca Ornaghi, Francesco Morena, Chiara Argentati, Manuela Valsecchi, Valeria Alberizzi, Roberta Di Guardo, Alessandra Bolino, Massimo Aureli, Sabata Martino, Angela Gritti

Summary: Combining lentiviral vector-based intracerebral gene therapy with bone marrow transplantation effectively extends lifespan and corrects neuroinflammatory and neurodegenerative phenotypes in SD mice, highlighting the synergic mode of action and therapeutic potential of this combined treatment strategy.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)

Article Clinical Neurology

Mutations in MYO9B are associated with Charcot-Marie-Tooth disease type 2 neuropathies and isolated optic atrophy

Silvia Cipriani, Marta Guerrero-Valero, Stefano Tozza, Edward Zhao, Veith Vollmer, Danique Beijer, Matt Danzi, Cristina Rivellini, Dejan Lazarevic, Giovanni Battista Pipitone, Bianca Rose Grosz, Costanza Lamperti, Stefania Bianchi Marzoli, Paola Carrera, Marcella Devoto, Chiara Pisciotta, Davide Pareyson, Marina Kennerson, Stefano C. Previtali, Stephan Zuchner, Steven S. Scherer, Fiore Manganelli, Martin Bahler, Alessandra Bolino

Summary: The study identified that novel or very rare variants in the MYO9B gene are associated with CMT2 and isolated OA. Functional studies showed that variants in MYO9B impair protein expression level and motor activity, indicating its essential role in peripheral and central nervous system axons.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Letter Clinical Neurology

Association between olfactory dysfunction and motor subtypes in Parkinson's disease: are non-tremor-dominant subtypes really uncorrelated to olfactory impairment?

Claudia Frau, Carla Masala, Paolo Solla, Tommaso Ercoli, Giovanni Defazio

NEUROLOGICAL SCIENCES (2023)

Article Biology

Olfactory Impairment Correlates with Executive Functions Disorders and Other Specific Cognitive Dysfunctions in Parkinson's Disease

Paolo Solla, Carla Masala, Tommaso Ercoli, Claudia Frau, Caterina Bagella, Ilenia Pinna, Francesco Loy, Giovanni Defazio

Summary: Olfactory and cognitive disorders are important non-motor symptoms in Parkinson's disease. The association between specific cognitive domains and olfactory impairment in Parkinson's disease patients has not been clearly established. This study aimed to evaluate the relationship between olfactory dysfunction and specific cognitive domains in patients compared to controls. The data suggested a significant association between olfactory dysfunction and deficit in executive functions.

BIOLOGY-BASEL (2023)

Review Clinical Neurology

Recent advances in the treatment of Charcot-Marie-Tooth neuropathies

Alessandra Bolino, Maurizio D'Antonio

Summary: Charcot-Marie-Tooth (CMT) neuropathies, despite a large number of identified causative genes, lack effective therapeutic options. However, recent advances in understanding disease mechanisms, animal modeling, and gene and molecular therapies have greatly improved the prospects of treating CMT, with several strategies progressing towards clinical trials.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2023)

Article Neurosciences

Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson's Disease Patients

Paolo Solla, Qian Wang, Claudia Frau, Valentina Floris, Francesco Loy, Leonardo Antonio Sechi, Carla Masala

Summary: The study aimed to determine whether olfactory impairment and other clinical characteristics can predict higher scores on the RBD screening questionnaire (RBDSQ) in PD patients. The severity of olfactory impairment was found to be closely correlated with RBD symptoms, and the study confirmed the presence of gender differences in RBD in PD patients.

BRAIN SCIENCES (2023)

Article Biology

Gender-Related Differences in the Correlation between Odor Threshold, Discrimination, Identification, and Cognitive Reserve Index in Healthy Subjects

Carla Masala, Paolo Solla, Francesco Loy

Summary: Many studies have shown significant associations between olfactory function and cognitive abilities in healthy individuals. However, the gender-related association between olfactory function and specific cognitive domains of the Cognitive Reserve Index (CRI) questionnaire has not been investigated. This study aimed to determine gender-related differences in the relationship between olfactory function and specific cognitive domains of the CRI questionnaire in healthy subjects.

BIOLOGY-BASEL (2023)

Letter Clinical Neurology

Seizure response to carbamazepine in a patient with CACNA1A-associated epilepsy: A case report

Francesca Pinna, Davide Corda, Chiara Fois, Alessandra Maccabeo, Gian Pietro Sechi, Paolo Solla

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2023)

Review Neurosciences

Neurological Consequences of COVID-19: A Systematic Review of the Pandemic's Impact on Neurology Training

Tommaso Ercoli, Francesco Barbato, Alessandro Bombaci, Luca Cuffaro, Francesco Di Lorenzo, Francesco Iodice, Michele Romoli, Paolo Solla, Giovanni Defazio

Summary: This study investigates the impact of COVID-19 on neurology training programs, collecting data on residents' experiences worldwide. The findings show significant effects of the pandemic on neurology training programs, emphasizing the importance of resilience and flexibility in medical education.

BRAIN SCIENCES (2023)

Article Immunology

The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis

Roberto Littera, Andrea Perra, Michela Miglianti, Ignazio S. Piras, Stefano Mocci, Sara Lai, Maurizio Melis, Teresa Zolfino, Cinzia Balestrieri, Maria Conti, Giancarlo Serra, Francesco Figorilli, Davide Firinu, Simona Onali, Laura Matta, Carmen Porcu, Francesco Pes, Daniela Fanni, Cristina Manieli, Monica Vacca, Roberto Cusano, Marcello Trucas, Selene Cipri, Stefania Tranquilli, Stefania Rassu, Federica Cannas, Mauro Giovanni Carta, Marta Anna Kowalik, Erika Giuressi, Gavino Faa, Luchino Chessa, Sabrina Giglio

Summary: This study highlights the positive immunomodulatory effect of HLA-G molecules on the clinical course of AIH-1 and how this improvement closely correlates with plasma levels of sHLA-G. However, the ambiguous role of HLA-G molecules expressed by plasma cells, which are pathognomonic features of AIH-1, raises a debate.

FRONTIERS IN IMMUNOLOGY (2022)

No Data Available